Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
130M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
36M
-
Shares change
-
+36M
-
Total reported value, excl. options
-
$1.13B
-
Value change
-
+$1.13B
-
Number of buys
-
38
-
Price
-
$31.61
Significant Holders of Vaxcyte, Inc. - COMMON STOCK (PCVX) as of Q2 2020
38 filings reported holding PCVX - Vaxcyte, Inc. - COMMON STOCK as of Q2 2020.
Vaxcyte, Inc. - COMMON STOCK (PCVX) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36M shares
of 130M outstanding shares and own 27.65% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (5.49M shares), TPG Group Holdings (SBS) Advisors, Inc. (5.16M shares), JANUS HENDERSON GROUP PLC (4.73M shares), FMR LLC (4.71M shares), Abingworth LLP (4.17M shares), FRAZIER MANAGEMENT LLC (2.31M shares), Medicxi Ventures Management (Jersey) Ltd (1.89M shares), WELLINGTON MANAGEMENT GROUP LLP (1.2M shares), NOVO Holdings A/S (882K shares), and MILLENNIUM MANAGEMENT LLC (868K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.